Share Name Share Symbol Market Type Share ISIN Share Description
Crimson Tide Plc LSE:TIDE London Ordinary Share GB0002080082 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 2.65p 116,882 08:00:00
Bid Price Offer Price High Price Low Price Open Price
2.50p 2.80p 2.65p 2.65p 2.65p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Technology Hardware & Equipment 2.40 0.07 0.02 132.5 12.0

Crimson Tide (TIDE) Latest News

More Crimson Tide News
Crimson Tide Takeover Rumours

Crimson Tide (TIDE) Share Charts

1 Year Crimson Tide Chart

1 Year Crimson Tide Chart

1 Month Crimson Tide Chart

1 Month Crimson Tide Chart

Intraday Crimson Tide Chart

Intraday Crimson Tide Chart

Crimson Tide (TIDE) Discussions and Chat

Crimson Tide Forums and Chat

Date Time Title Posts
17/5/201918:57Crimson Tide PLC384
13/1/201414:52The new island of Tide, home to Chen of old151

Add a New Thread

Crimson Tide (TIDE) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2019-05-22 12:45:132.5015,605390.13O
2019-05-22 08:34:452.53100,0002,530.00O
2019-05-22 07:54:522.741,27734.99O
View all Crimson Tide trades in real-time

Crimson Tide (TIDE) Top Chat Posts

Crimson Tide Daily Update: Crimson Tide Plc is listed in the Technology Hardware & Equipment sector of the London Stock Exchange with ticker TIDE. The last closing price for Crimson Tide was 2.65p.
Crimson Tide Plc has a 4 week average price of 2.50p and a 12 week average price of 2.50p.
The 1 year high share price is 3.70p while the 1 year low share price is currently 1.95p.
There are currently 454,486,234 shares in issue and the average daily traded volume is 575,714 shares. The market capitalisation of Crimson Tide Plc is £12,043,885.20.
hydrus: The forecast I've seen was £1.8m revenue for year ending December 2017 so actually I think they are well ahead. Agreed though that profits are below expectations. At this stage though with low revenues profits are going to be pretty small whatever so important they focus on growing the top line which they clearly are. They've signposted revenue growth of circa 23% again in 2018 and then accelerating growth in following 2 years which sounds good to me.You may well be right though re next 12-18 months not a lot happening with share price. I have a smallish position here and happy to hold and see where they get to in 2-3 years.
jamielein: I decided to sell today. Possibly the wrong decision but profits will fall short of market expectations [EPS this year was expected to be 0.22p but will be similar to last year (0.08p)], and revenue was light too [£2.3m now expected vs. £2.5m forecast]. I've been holding since mid-2015 and have been disappointed with the lack of share price progress over the last couple of years. The chart has been looking quite weak for some time so I've decided to exit. I understand the lower than expected profits are due to investment in people and marketing, however they've previously been able to grow profits significantly year on year over the last few years. Although this company has great growth prospects, I'm not convinced that the shares will do much for the foreseeable future so my decision is purely short-term in nature (12-18 months) rather than having doubts over the company's success over the long term.
jamielein: The company has actually made a profit over the last few years and their profits have been growing. This is another large contract, which I would hope is renewed after 2 years if their product is well received. It's worth nothing that they are however on a high rating already so I'm not expecting a massive increase in share price anytime soon (I still hold by the way). Edit: I meant 4 years as it's a 48 month contract
bapodra_investments: One of the biggest problems with this share is liquidity and lack of volume. It is simply too small to even be considered by some institutional investors. The only one that has any significant holding over 3% is Helium Special Situations Fund which has around 20% but there is no Octopus, Miton, Marlborough, Hargreaves Hale, etc. This company turns over less than £2m per annum. It has a market cap of around £15m. This will include future potential earnings built into the share price. This company will have to start achieving turnover of around £3m as a starting point and look to increase it every year which it is simply not managed over the past 6-7 years. However, as others on this board state it is different this time. It will need to be as if it is not then the share price will not be appreciating to levels we all hope.
bapodra_investments: Could there be a small glimmer of hope with a potential small breakout forming? I think some super patience will be needed for this company to even double its share price from here.
bapodra_investments: Shuffle, I agree with you but the key point is following years ahead that you make. So how do you take their statement of increased expenditure impacting bottom line performance for 2017? They have made this statement themselves in the results recently. Therefore the share price will not appreciate in line with growth potential for future years until the impact on the bottom line is determined for 2017. That is my opinion but lets see what the share price does over the next 12 months.
bapodra_investments: From the Prelinimary Results December 2016 the following concerns me: " The majority of the increased expenditure will be incurred in this current financial year and will therefore impact the bottom line performance of the group for 2017." Therefore the 2017 results may show a loss or less profit than 2016 due to above which surely is going to have a major impact on the share price over the next 12 months. Do others agree or disagree with this?
bapodra_investments: Well the share price did not react at all to the results which means they were already priced in. It seems only positive contract RNS's which are significantly revenue enhancing are going to drive this further upwards.
bapodra_investments: Preliminary results out. RNS is positive. Revenue has increased and so too has profit before tax. It has doubled 100% from last year which doubled 100% from the year before. The only slight concern is the increased expenditure which will be incurred in this financial year so will show in next years accounts. This should not have any impact on turnover but could have an impact on profitability in next years accounts. However an excellent RNS and it will be interesting to see how the share price reacts.
glasshalfull: Courtesy to say I've been buying here over the last couple of months, although you wouldn't realise with the share price pull-back!!! Also delighted with today's update which sets TIDE up nicely for 2017. WH Ireland provide the following brief update on the back of today's t/s, "...positive update from TIDE this morning confirming not only that trading in the current year to 31 December is in line with expectations but also signalling that it has already absorbed some of the costs of a step change in investment to grow a much larger business in 2017 and beyond. For 2016, TIDE confirms revenue for the year is expected to total £1.8m (WHI £1.8m) whilst we look for a reported PBT of £0.4m, double the 2015 result. Staff count has also doubled in the past 18 months. One key takeaway from today's update is that the rollout of the major supermarket contract has been completed ahead of forecast hence revenues are now being recognised on the whole estate. Whilst this will clearly have some minor benefit in 2016, it means TIDE starts 2017 at full pelt underpinning future investment plans. This statement rounds off a hugely successful year for TIDE with three main contract wins/ extensions including a long-term tie up with the National Centre for Hereditary Disorders in Ireland (the first significant breakthrough into the Healthcare sector) and its largest ever multi-year contract signed with a UK supermarket in October. TIDE is utilising this momentum to step up investment in growing a much bigger business, the size and scope of which should become clearer in the New Year when we expect to revisit our 2017 and 2018 forecasts." --- Kind regards, GHF
Crimson Tide share price data is direct from the London Stock Exchange
Your Recent History
Crimson Ti..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190522 23:39:34